Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma.
about
Prognostic Value and Clinicopathological Significance of p-stat3 Among Gastric Carcinoma Patients: A Systematic Review and Meta-AnalysisEndothelial cell-derived interleukin-6 regulates tumor growth.A-to-I RNA editing of BLCAP lost the inhibition to STAT3 activation in cervical cancer.Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection.Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1A novel curcumin analog (H-4073) enhances the therapeutic efficacy of cisplatin treatment in head and neck cancerAlterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis.MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.Girdin expression in cervical carcinoma and its role in the malignant properties of HeLa cells.First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy.Functional regulatory role of STAT3 in HPV16-mediated cervical carcinogenesisCombination treatment with flavonoid morin and telomerase inhibitor MST‑312 reduces cancer stem cell traits by targeting STAT3 and telomerase.Deficiency of Erbin induces resistance of cervical cancer cells to anoikis in a STAT3-dependent manner.Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis.BCL3 exerts an oncogenic function by regulating STAT3 in human cervical cancer.STAT3 activation in tumor cell-free lymph nodes predicts a poor prognosis for gastric cancer.Genetic Interactions of STAT3 and Anticancer Drug Development.The involvement of JAK-STAT3 in cell motility, invasion, and metastasis.STAT3 in Cancer-Friend or Foe?The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours.Inhibition of STAT3 with the Generation 2.5 Antisense Oligonucleotide, AZD9150, Decreases Neuroblastoma Tumorigenicity and Increases Chemosensitivity.STAT3 correlates with stem cell-related transcription factors in cervical cancer.Novel carbazole inhibits phospho-STAT3 through induction of protein-tyrosine phosphatase PTPN6.Nicotine promotes apoptosis resistance of breast cancer cells and enrichment of side population cells with cancer stem cell-like properties via a signaling cascade involving galectin-3, α9 nicotinic acetylcholine receptor and STAT3.Effect of STAT5 silenced by siRNA on proliferation apoptosis and invasion of esophageal carcinoma cell line Eca-109.Correlation of activated STAT3 expression with clinicopathologic features in lung adenocarcinoma and squamous cell carcinoma.STAT3, a Poor Survival Predicator, Is Associated with Lymph Node Metastasis from Breast Cancer.STAT3 influences the characteristics of stem cells in cervical carcinomaBoth STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma.Amorfrutin A inhibits TNF-α induced JAK/STAT signaling, cell survival and proliferation of human cancer cells.Targeting the IL-6/JAK/STAT3 signalling axis in cancer.Autocrine/paracrine erythropoietin signalling promotes JAK/STAT-dependent proliferation of human cervical cancer cells.Increased signal transducer and activator of transcription 3 (STAT3) and decreased cyclin D1 in recurrent astrocytic tumours compared with paired primary astrocytic tumours.Biochemical Properties of a Decoy Oligodeoxynucleotide Inhibitor of STAT3 Transcription Factor.Hunting for transcription factors: STAT3 decoy in non-small cell lung cancerGPRC5A: An Emerging Biomarker in Human Cancer
P2860
Q26769034-91CC1D54-62B6-4F17-A799-2E3ACE043302Q33592677-52BBEC81-76C4-4440-A4D3-FD1DC66C1123Q33889216-03E0B2BC-2F83-4B7F-B36B-AE475E65BC82Q34321805-3823E70E-EF82-4993-96FF-DC4C28CE8953Q34430583-8341E237-0CD9-49A5-82D5-EFE54C7D0034Q35133375-3C750A35-FF94-4BE7-853B-DC06991106F8Q35655840-067D9757-C30A-4C98-9CEC-3E44F8FD159AQ36413160-FC68AF5C-BE43-44B6-9109-C0A42C27A463Q36742100-32A98DF4-0BAB-4DC0-8A84-02C246FBA6FEQ36890491-73CF6FFB-1711-4ED5-B231-92DB8221F620Q37024935-21834BF8-241E-4E38-A5F5-4AEEF2AFA45BQ37042617-C0CAC0AE-6C04-41B8-8734-FE94399534D2Q37087116-2A08B2F8-6BFE-41CD-B3DD-63670AE2ED92Q37190200-330ADCD1-5ED6-453E-B968-195DD49671A5Q37381520-DA319E37-618C-4E8C-BB7C-01B2D45FD4E2Q37676782-F77A7AA3-8DC2-4850-9B35-57AB90BC871DQ38198930-84839FF5-3476-42DA-9965-ED875F2326DBQ38208007-E0F71F68-7699-4265-8373-CFE02C3C60B5Q38226313-6E243A7B-D17A-4284-9D6C-3B47BE19A6A8Q38543552-2F7DE882-77DD-4DC8-AB5D-ED873BC7D7B8Q38734933-CA10F9BA-7069-400E-A3E8-03BE3D52FE45Q38811621-B8075721-0D66-497B-8149-65790737E845Q38979718-1A416F88-2F40-47FD-8419-34FFB087D056Q39011785-D4ABA4A5-6CCA-4D2D-994F-1A6ECD52D39DQ39115400-29E9FDC5-9FEA-44B3-BB00-057A030D4AC2Q39669033-1B903CBE-DCC5-4332-A6F1-5632064AC283Q39831857-33D826D1-CE2C-4AF5-B723-56D4EB1F9679Q41144812-70A2B53F-85B7-4ED2-81C4-F6EBD394A3C6Q42276113-A7A4680E-519D-4160-A9B4-2479025FD909Q47844034-67D83198-27F1-4475-BE66-AC41B891B97EQ50191433-3F904EEE-1BDE-4707-B56F-0A0C2ADB86A8Q54380871-80EB63EB-CBDC-4523-A839-5670C551346EQ55462311-B3D19A68-CBCD-48F6-9CCA-99689E2F1F8BQ55642764-6A50F442-14D8-4CD4-84EB-E514B50AF163Q58562380-40C4F068-E4F3-460F-934B-FE07827B978FQ58695542-E0B05A78-1F8B-4A09-AD74-436C3814E6BE
P2860
Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expression of activated signal ...... vical squamous-cell carcinoma.
@en
Expression of activated signal ...... vical squamous-cell carcinoma.
@nl
type
label
Expression of activated signal ...... vical squamous-cell carcinoma.
@en
Expression of activated signal ...... vical squamous-cell carcinoma.
@nl
prefLabel
Expression of activated signal ...... vical squamous-cell carcinoma.
@en
Expression of activated signal ...... vical squamous-cell carcinoma.
@nl
P2093
P2860
P356
P1476
Expression of activated signal ...... rvical squamous-cell carcinoma
@en
P2093
K Ushijima
N Fujiyoshi
S Takemoto
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605212
P407
P50
P577
2009-07-28T00:00:00Z